Market Survey on Acute Kidney Injury Treatment Market Covering Sales Outlook, Up-to-date Key Trends, Market Size and Forecast, Per Capita Expenditure, Company Share, Brand Share, Regulations, Reimbursement Scenario, Epidemiology, Procedure Numbers, and Pipeline Assessment
An In-depth Market Insights of Acute Kidney Injury Treatment Market including Dialysis and Drug Therapy Covering 30+ Countries like United States, United Kingdom, Germany, France, Norway, Sweden, Saudi Arabia, United Arab Emirates, Japan, Korea, Australia, New Zealand, and Others
Acute Kidney Injury Treatment Market Outlook (2022 to 2029)
The global Acute Kidney Injury Treatment Market is expected to witness staggering growth, registering an 8.2% CAGR during the forecast period (2022 to 2029). The overall demand for acute kidney injury treatment is expected to surpass a valuation of US$ 2,058.2 Million in 2022 and is projected to reach US$ 3,566.7 Million by the end of 2029.
Attribute
Details
Acute Kidney Injury Treatment Market Size Value in 2014
US$ 1,177.7 Million
Acute Kidney Injury Treatment Market Size Value in 2029
US$ 3,566.7 Million
Acute Kidney Injury Treatment Market Historical CAGR (2014 to 2021)
7.1%
Acute Kidney Injury Treatment Market CAGR (2022 to 2029)
8.2%
The rising incidence of acute kidney injuries and the increasing rate of dialysis therapies are primary factors driving the acute kidney injury treatment market. Besides this, growing awareness regarding the early prognosis of this injury will also fuel the demand for acute kidney injury treatment worldwide.
Regionally, North America is anticipated to account for the largest share of the global acute kidney injury treatment market. As per the study, over 40.8% of acute kidney injury treatment sales are expected to concentrate in North America through 2022.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
How The Market Progressed Till June 2022?
Particulars
Details
H1, 2021
8.11%
H1, 2022 Projected
8.17%
H1, 2022 Outlook
6.97%
BPS Change - H1, 2022 (O) – H1, 2022 (P)
(-) 120 ↓
BPS Change – H1, 2022 (O) – H1, 2021
(-) 114 ↓
The H1-2022 outlook period in comparison to H1-2022 projected period showed a negative growth in terms of Basis Point Share by 120 BPS. In H1-2022, the growth rate of the acute kidney injury treatment market is expected to fall by 114 basis point shares (BPS), as per FMI analysis.
The market shows a decline in the BPS values, owing to the substantial inpatient costs incurred by patients with acute kidney injury (AKI). Moreover, patients with dialysis requirements experience a greater burden associated with healthcare costs due to longer hospitalization. The substantial difference in pricing for acute kidney injury treatment and care in hospital settings has thus resulted in a drop in the BPS values.
The market is influenced by several macro and industrial dynamics, such as disease prevalence, and target population group demography. The key developments in this market include the advancements in the current understanding of renal injury and repair signaling for better management of AKI.
Conversely, the development of novel biomarkers which aid with the differentiation of AKI from Acute tubular necrosis (ATN), has presented opportunities for enhanced disease diagnosis, identification, and management, thus providing a positive outlook towards market growth.
2014 to 2021 Acute Kidney Injury (AKI) Treatment Market Outlook In Comparison To 2022 to 2029 Forecast
As per Future Market Insights (FMI), the global acute kidney injury treatment market grew at 7.1% CAGR between 2014 and 2021. The demand for acute kidney injury treatment is expected to increase two-fold, exceeding US$ 1,897.7 Million through 2021 & beyond.
Advancements in diagnostic technology and growing cases of acute kidney injuries are expected to bolster the growth in the market. With increasing kidney-related disorders across the globe, the number of dialysis centers has surged worldwide.
As the rate of acute kidney injury cases is increasing, patients are actively seeking advanced acute renal disease treatment. On account of this, healthcare professionals are adopting advanced diagnostic equipment to enhance the detection of disease and improve the care of patients.
Besides this, the growing adoption of advanced treatment across emerging economies such as India, Japan, and China is propelling growth in the East and South Asia markets. Backed by these aforementioned factors, the global acute injury treatment market is poised to expand at 8.2% CAGR between 2022 and 2029, surpassing US$ 2,237.2 Million by the end of 2023.
Find your sweet spots for generating winning opportunities in this market.
Which Are The Key Trends Driving The Acute Kidney Injury Treatment Market?
The advent of Tech-Driven AKI Treatment to Drive the Acute Kidney Injury Treatment Market
According to the International Society of Nephrology (ISN), around 13.3 million people suffer from acute kidney injury (AKI). Among these, nearly 11.3 million cases are from emerging economies such as India, China, Africa, and Japan.
Out of 1.7 million deaths globally every year due to AKI, around 1.4 million occur in low- and middle-income economies. To reduce the global burden of acute renal diseases and kidney injuries, the demand for advanced diagnostic treatment is increasing.
Conventional dialysis systems require manual adjustments for every individual and parameter. However, with the advancements in technology and integration of artificial intelligence in AKI stage 1 treatment, automated dialysis treatment is delivering enhanced care to patients.
These new-age dialysis machines enable all the parameters automatically, minimizing human intervention. Moreover, key players are improving the efficiency of dialysis, including the usage of high-flux and high-efficacy membranes, emanating from technical advances.
This is expected to boost the global acute kidney injury treatment market over the forecast period (2022 to 2029).
What Are The Factors Limiting The Growth In Acute Kidney Injury Treatment Market?
High-Cost Associated with AKI Treatment Equipment Might Impede the Sales
While new product development and the introduction of portable, automated AKI equipment favoring growth in developed economies, high-cost associated with this equipment might impede sales in low-income countries.
Besides this, the lack of early disease detection and awareness regarding kidney-related diseases and acute kidney injuries in emerging economies will also hamper the growth of the market.
However, governments in countries such as India and China are introducing reimbursement policies to offer treatment at a low cost. Some private healthcare organizations are also undertaking several initiatives and projects to increase awareness regarding AKI.
This is expected to aid the growth of the acute kidney injury treatment market, especially across the Asia Pacific and Latin America.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Country-Wise Analysis
Which are the Factors Driving the USA Acute Kidney Injury Treatment Market?
Rising Awareness for Acute Renal Disease Treatment to Augment Growth
As per Future Market Insights, North America is expected to dominate the market, with the USA leading the growth in North America. Primary factors underpinning the growth in the market include the rising prevalence of kidney-related disorders and rapid development in diagnostic equipment.
According to the research, nearly 786,000 people are living with kidney-related disorders in the USA Among 1000 persons 55 of them are hospitalized with severe acute kidney injury diagnoses. Out of which 5% succumb to the disease every year, states medical research in the USA
With rising awareness regarding acute renal disease treatment, the development of advanced and automated AKI diagnostic equipment is surging in the USA Several private healthcare organizations are increasing the adoption of advanced AKI equipment to enhance the care to the patients.
On account of this, several leading players are eyeing the USA market to increase their revenue through product development and new launches in the country. A slew of such developments by key players are expected to bolster the growth in the USA market.
What is the India Acute Kidney Injury Treatment Market Outlook?
Surging Prevalence of AKI to Increase the Demand for Acute Kidney Diseases Treatment
According to the ISN, nearly 1.4 million succumb to acute kidney injuries in low and middle-income countries, among which the majority of the cases are recorded in India. Due to the rising prevalence of AKI, the number of dialysis centers has surged in the country.
With the establishment of these centers, the adoption of AKI treatment equipment is increasing among healthcare professionals. Additionally, rapid technological advancements in healthcare infrastructure and favorable government policies are also improving the adoption of advanced AKI equipment and diagnostic treatment.
Also, increasing awareness regarding the treatment for acute kidney disease is expected to boost the sales of AKI treatment diagnostic equipment in these dialysis centers. Subsequently, rising disposable income and growing health consciousness have enabled patients to opt for advanced treatment for these diseases.
Backed by these aforementioned factors, key players aiming for novel product development and launches in India. This is expected to create a conducive environment for the acute kidney injury treatment market in India.
Will the Demand for Acute Kidney Injury Treatment in China Increase?
Influenced by Well-Established Healthcare Infrastructure, China AKI Treatment Market is Set to Gain Traction
China is one of the fastest-growing markets for acute kidney injury treatment. Growth in the country is attributable to the rising incidence of kidney-related diseases and the expansion of the healthcare industry.
With the growing prevalence of pre-renal injuries in China, the rate of hospitalization, especially for the geriatric population has increased. Hence, the adoption of dialysis equipment and drug-induced therapies has surged in China’s healthcare industry.
Also, the government in China is adopting various initiatives and introducing projects to create awareness regarding AKI and kidney-related diseases.
For instance, in 2017, China’s central government issued the 13th Five-Year National Science and Technology Innovation Plan, which aims to create a national platform to share biomedical big data
The expansion of the healthcare industry and the adoption of automated diagnostic equipment is favoring the growth in the China market. On the back of developing the healthcare industry, key players are streamlining their projects and introducing new products in China.
Such factors are projected to propel the growth in China's acute kidney injury treatment market over the forecast period.
Category-Wise Insights
Which Product Type is More Preferred in the Acute Kidney Injury Treatment Market?
Dialysis and Pre-Renal Injury to Account for Maximum Share in Acute Kidney Injury Treatment Market
In terms of product type, the dialysis segment is expected to account for the maximum revenue share during the forecast period. With the growing prevalence of acute kidney injury, the establishment of dialysis centers across the globe has increased.
As per Future Market Insights, dialysis is expected to remain the most preferred and efficient treatment for AKI. Around 9 out of 10 healthcare professionals suggest and opt for dialysis. As intermittent hemodialysis has excellent efficiency, patients are actively seeking this treatment.
Consequently, governments in emerging economies are establishing an increasing number of dialysis centers. Besides this, the growing prevalence of pre-renal injury is also aiding the growth of the dialysis segment.
In terms of injury type, the pre-renal injury segment is expected to contribute over 60.7% of sales in the acute kidney injury treatment market, as it covers the maximum patient population.
Which is the Preferred Distribution Channel in Acute Kidney Injury Treatment Market?
Hospitals to Contribute over 50% of Global Acute Kidney Injury Treatment Market Sales
In terms of distribution channels, hospitals are expected to gain the maximum share of the acute kidney injury treatment market. According to FMI, over 80% of sales in the market are contributed by hospitals and ambulatory surgical centers, collectively.
However, with well-established infrastructure and the availability of diagnostic equipment in hospitals, governments in several countries are increasing the supply of AKI treatment equipment in hospitals.
Hospitals in several low and middle-income countries are receiving equipment under the initiative of developing healthcare infrastructure by the government and private organizations.
For instance, according to the India Brand Equity Foundation, in 2021, the Ministry of AYUSH was allocated US$ 407.84 million to develop the healthcare infrastructure. By 2025, with favorable investment Government of India is planning to increase public health spending by 2.5% of the country’s GDP.
Competitive Landscape
Leading players in the global acute kidney injury treatment market are focusing on developing automated, portable, and tech-driven dialysis equipment to deliver advanced care to patients. They are also integrating advanced technologies such as artificial intelligence and the Internet of Things (IoT) to expand their product portfolio.
Meanwhile, some of the other players are making advancements in diagnostic technology in order to streamline their product offerings in emerging economies with diverse product portfolios.
For instance:
In March 2021, C-Path announced the launch of an acute kidney injury project in partnership with the USA Food and Drug Administration (FDA) for Drug Evaluation and Research, the Office of translational science, and the Division of cardiology and Nephrology, to develop a suite of prognostic tools to improve the detection of drug-induced kidney injury.
In June 2021, Abionyxx announced the enrollment of the first patient in its Phase-2a clinical study with CER-001 for the treatment of septic patients at high risk of developing acute kidney injury.
Scope Of Report
Attribute
Details
Forecast Period
2022 to 2029
Historical Data Available for
2014 to 2021
Market Analysis
US$ Million for Value
Key Regions Covered
North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East and Africa(MEA)
Key Countries Covered
USA, Canada, Brazil, Mexico, Germany, United Kingdom, France, Italy, Spain, Nordic, Russia, Poland, China, India, Thailand, Indonesia, Australia and New Zealand, Japan, GCC countries, North Africa, South Africa, and others.
Key Market Segments Covered
Product, Injury, Distribution Channel, and Region
Key Companies Profiled
Novartis, Pfizer Inc.
Merck & Co.
Biocon Ltd.
Teva Pharmaceutical Industries Ltd.
Mylan Pharmaceuticals Inc.
NIPRO Medical
Baxter Corporation
Asahi Kasei
NIKKISO
Fresenius Medical Care
Others
Pricing
Available upon Request
Acute Kidney Injury Treatment Market By Category
Product:
Dialysis
Intermittent Hemodialysis
Continuous Renal Replacement Therapy (CRRT)
Sustained Low-Efficiency Dialysis (SLED)
Drug Therapy
Antibiotics
Diuretics
Immunosuppressive Agents
Injury:
Pre-renal Injury
Intrinsic Renal Injury
Post-renal Injury
Distribution Channel:
Hospitals
Ambulatory Surgical Centers
Others
Region:
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa(MEA)
Table of Content
1. Executive Summary | Acute Kidney Injury Treatment Market
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition
3. Key Market Trends
3.1. Key Trends Impacting the Market
4. Key Success Factors
4.1. Pipeline Assessment
4.2. Unmet needs
5. Global Market Demand (in Value or Size in US$ Million) Analysis 2014 to 2021 and Forecast, 2022 to 2029
5.1. Historical Market Value (US$ Million) Analysis, 2014 to 2021
5.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2029
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
6. Market Background
6.1. Macro-Economic Factors
6.1.1. Global GDP Growth Outlook
6.1.2. Global Healthcare Spending Outlook
6.2. Market Dynamics
6.2.1. Drivers
6.2.2. Restraints
6.2.3. Opportunity Analysis
7. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by Injury
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Million) Analysis By Injury, 2014 to 2021
7.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Injury, 2022 to 2029
7.3.1. Pre-renal Injury
7.3.2. Intrinsic Renal Injury
7.3.3. Post-renal Injury
7.4. Market Attractiveness Analysis By Injury
8. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by Product
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Million) Analysis By Therapy, 2014 to 2021
8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Therapy, 2022 to 2029
8.3.1. Drug Therapy
8.3.1.1. Isotonic Solutions
8.3.1.2. Antibiotics
8.3.1.3. Diuretics
8.3.1.4. Immunosuppressive agents
8.3.2. Dialysis
8.3.2.1. Intermittent Hemodialysis
8.3.2.2. Continuous Renal Replacement Therapy (CRRT)
8.3.2.3. Sustained Low-Efficiency Dialysis (SLED)
8.4. Market Attractiveness Analysis By Therapy
9. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by Distribution Channel
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) Analysis By Sales Channels, 2014 to 2021
9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Distribution Channel, 2022 to 2029
9.3.1. Hospitals
9.3.2. Ambulatory Surgical Centers
9.3.3. Others Market Attractiveness Analysis By Distribution Channel
10. Global Market Analysis 2014 to 2021 and Forecast 2022 to 2029, by Region
10.1. Introduction
10.2. Historical Market Size (US$ Million) Analysis By Region, 2014 to 2021
10.3. Current Market Size (US$ Million) Analysis and Forecast By Region, 2022 to 2029
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. South Asia
10.3.5. East Asia
10.3.6. Oceania
10.3.7. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis By Region
11. North America Market Analysis 2014 to 2021 and Forecast 2022 to 2029
11.1. Introduction
11.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2014 to 2021
11.3. Market Size (US$ Million) and Volume Forecast By Market Taxonomy, 2022 to 2029
11.3.1. By Country
11.3.1.1. USA
11.3.1.2. Canada
11.3.2. By Injury
11.3.3. By Therapy
11.3.4. By Distribution Channel
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Injury
11.4.3. By Therapy
11.4.4. By Distribution Channel
11.5. Drivers and Restraints - Impact Analysis
12. Latin America Market Analysis 2014 to 2021 and Forecast 2022 to 2029
12.1. Introduction
12.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2014 to 2021
12.3. Market Size (US$ Million) and Volume Forecast By Market Taxonomy, 2022 to 2029
12.3.1. By Country
12.3.1.1. Brazil
12.3.1.2. Argentina
12.3.1.3. Mexico
12.3.1.4. Rest of Latin America
12.3.2. By Injury
12.3.3. By Therapy
12.3.4. By Distribution Channel
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Injury
12.4.3. By Therapy
12.4.4. By Distribution Channel
12.5. Drivers and Restraints - Impact Analysis
13. Europe Market Analysis 2014 to 2021 and Forecast 2022 to 2029
13.1. Introduction
13.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2014 to 2021
13.3. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029
13.3.1. By Country
13.3.1.1. Germany
13.3.1.2. United Kingdom
13.3.1.3. France
13.3.1.4. France
13.3.1.5. Italy
13.3.1.6. Spain
13.3.1.7. Russia
13.3.1.8. Rest of Europe
13.3.2. By Injury
13.3.3. By Therapy
13.3.4. By Distribution Channel
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Injury
13.4.3. By Therapy
13.4.4. By Distribution Channel
13.5. Drivers and Restraints - Impact Analysis
14. South Asia Market Analysis 2014 to 2021 and Forecast 2022 to 2029
14.1. Introduction
14.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021
14.3. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029
14.3.1. By Country
14.3.1.1. India
14.3.1.2. Thailand
14.3.1.3. Indonesia
14.3.1.4. Malaysia
14.3.1.5. Rest of South Asia
14.3.2. By Injury
14.3.3. By Therapy
14.3.4. By Distribution Channel
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Injury
14.4.3. By Therapy
14.4.4. By Distribution Channel
14.5. Drivers and Restraints - Impact Analysis
15. East Asia Market Analysis 2014 to 2021 and Forecast 2022 to 2029
15.1. Introduction
15.2. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2014 to 2021
15.3. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029
15.3.1. By Country
15.3.1.1. China
15.3.1.2. Japan
15.3.1.3. South Korea
15.3.2. By Injury
15.3.3. By Therapy
15.3.4. By Sales Channel
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Injury
15.4.3. By Therapy
15.4.4. By Distribution Channel
15.5. Drivers and Restraints - Impact Analysis
16. Oceania Market Analysis 2014 to 2021 and Forecast 2022 to 2029
16.1. Introduction
16.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2014 to 2021
16.3. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029
16.3.1. By Country
16.3.1.1. Australia
16.3.1.2. New Zealand
16.3.2. By Injury
16.3.3. By Therapy
16.3.4. By Distribution Channel
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Injury
16.4.3. By Therapy
16.4.4. By Distribution Channel
16.5. Drivers and Restraints - Impact Analysis
17. Middle East and Africa Market Analysis 2014 to 2021 and Forecast 2022 to 2029
17.1. Introduction
17.2. Historical Market Size (US$ Million) Analysis By Market Taxonomy, 2014 to 2021
17.3. Market Size (US$ Million) Forecast By Market Taxonomy, 2022 to 2029
17.3.1. By Country
17.3.1.1. GCC Countries
17.3.1.2. Turkey
17.3.1.3. Northern Africa
17.3.1.4. South Africa
17.3.1.5. Rest of Middle East and Africa
17.3.2. By Injury
17.3.3. By Therapy
17.3.4. By Distribution Channel
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Injury
17.4.3. By Therapy
17.4.4. By Distribution Channel
17.5. Drivers and Restraints - Impact Analysis
18. Emerging Countries Market Analysis 2014 to 2021 and Forecast 2022 to 2029
18.1. Introduction
18.1.1. Market Value Proportion Analysis, By Key Countries
18.1.2. Global Vs. Country Growth Comparison
18.2. China Market Analysis
18.2.1. Introduction
18.2.2. Market Value Proportion Analysis by Market Taxonomy
18.2.3. Market Value (US$ Million) Analysis and Forecast by Market Taxonomy
18.2.3.1. By Injury
18.2.3.2. By Therapy
18.2.3.3. By Distribution Channel
18.2.4. China Market - Competition Landscape
18.3. India Market Analysis
18.3.1. Introduction
18.3.2. Market Value Proportion Analysis by Market Taxonomy
18.3.3. Market Value (US$ Million) Analysis and Forecast by Market Taxonomy
18.3.3.1. By Injury
18.3.3.2. By Therapy
18.3.3.3. By Distribution Channel
18.3.4. India Market - Competition Landscape
18.4. Brazil Market Analysis
18.4.1. Introduction
18.4.2. Pricing Analysis
18.4.3. PEST Analysis
18.4.4. Market Value Proportion Analysis by Market Taxonomy
18.4.5. Market Value (US$ Million) Analysis and Forecast by Market Taxonomy
18.4.5.1. By Injury
18.4.5.2. By Therapy
18.4.5.3. By Distribution Channel
18.4.6. Brazil Market - Competition Landscape
19. Key Countries Analysis
19.1. USA Market Analysis 2014 to 2021 and Forecast 2022 to 2029
19.1.1. Introduction
19.1.2. Historical Market Size (US$ Million) & Volume Units Trend Analysis By Market Taxonomy, 2014 to 2021
19.1.3. Market Size (US$ Million) & Volume Units Forecast By Market Taxonomy, 2022 to 2029
19.1.3.1. By Injury
19.1.3.2. By Therapy
19.1.3.3. By Distribution Channel
19.1.4. Market Attractiveness Analysis
19.2. Canada Market Analysis 2014 to 2021 and Forecast 2022 to 2029
19.2.1. Introduction
19.2.2. Historical Market Size (US$ Million) & Volume Units Trend Analysis By Market Taxonomy, 2014 to 2021
19.2.3. Market Size (US$ Million) & Volume Units Forecast By Market Taxonomy, 2022 to 2029
19.2.3.1. By Injury
19.2.3.2. By Therapy
19.2.3.3. By Distribution Channel
19.2.4. Market Attractiveness Analysis
19.3. Germany Market Analysis 2014 to 2021 and Forecast 2022 to 2029
19.3.1. Introduction
19.3.2. Historical Market Size (US$ Million) & Volume Units Trend Analysis By Market Taxonomy, 2014 to 2021
19.3.3. Market Size (US$ Million) & Volume Units Forecast By Market Taxonomy, 2022 to 2029
19.3.3.1. By Injury
19.3.3.2. By Therapy
19.3.3.3. By Distribution Channel
19.3.4. Market Attractiveness Analysis
19.4. United Kingdom Market Analysis 2014 to 2021 and Forecast 2022 to 2029
19.4.1. Introduction
19.4.2. Historical Market Size (US$ Million) & Volume Units Trend Analysis By Market Taxonomy, 2014 to 2021
19.4.3. Market Size (US$ Million) & Volume Units Forecast By Market Taxonomy, 2022 to 2029
19.4.3.1. By Injury
19.4.3.2. By Therapy
19.4.3.3. By Distribution Channel
19.4.4. Market Attractiveness Analysis
19.5. France Market Analysis 2014 to 2021 and Forecast 2022 to 2029
19.5.1. Introduction
19.5.2. Historical Market Size (US$ Million) & Volume Units Trend Analysis By Market Taxonomy, 2014 to 2021
19.5.3. Market Size (US$ Million) & Volume Units Forecast By Market Taxonomy, 2022 to 2029
19.5.3.1. By Injury
19.5.3.2. By Therapy
19.5.3.3. By Distribution Channel
19.5.4. Market Attractiveness Analysis
19.6. Italy Market Analysis 2014 to 2021 and Forecast 2022 to 2029
19.6.1. Introduction
19.6.2. Historical Market Size (US$ Million) & Volume Units Trend Analysis By Market Taxonomy, 2014 to 2021
19.6.3. Market Size (US$ Million) & Volume Units Forecast By Market Taxonomy, 2022 to 2029
19.6.3.1. By Injury
19.6.3.2. By Therapy
19.6.3.3. By Distribution Channel
19.6.4. Market Attractiveness Analysis
19.7. Spain Market Analysis 2014 to 2021 and Forecast 2022 to 2029
19.7.1. Introduction
19.7.2. Historical Market Size (US$ Million) & Volume Units Trend Analysis By Market Taxonomy, 2014 to 2021
19.7.3. Market Size (US$ Million) & Volume Units Forecast By Market Taxonomy, 2022 to 2029
19.7.3.1. By Injury
19.7.3.2. By Therapy
19.7.3.3. By Distribution Channel
19.7.4. Market Attractiveness Analysis
19.8. Russia Market Analysis 2014 to 2021 and Forecast 2022 to 2029
19.8.1. Introduction
19.8.2. Historical Market Size (US$ Million) & Volume Units Trend Analysis By Market Taxonomy, 2014 to 2021
19.8.3. Market Size (US$ Million) & Volume Units Forecast By Market Taxonomy, 2022 to 2029
19.8.3.1. By Injury
19.8.3.2. By Therapy
19.8.3.3. By Distribution Channel
19.8.4. Market Attractiveness Analysis
19.9. Japan Market Analysis 2014 to 2021 and Forecast 2022 to 2029
19.9.1. Introduction
19.9.2. Historical Market Size (US$ Million) & Volume Units Trend Analysis By Market Taxonomy, 2014 to 2021
19.9.3. Market Size (US$ Million) & Volume Units Forecast By Market Taxonomy, 2022 to 2029
19.9.3.1. By Injury
19.9.3.2. By Therapy
19.9.3.3. By Distribution Channel
19.9.4. Market Attractiveness Analysis
19.10. South Korea Market Analysis 2014 to 2021 and Forecast 2022 to 2029
19.10.1. Introduction
19.10.2. Historical Market Size (US$ Million) & Volume Units Trend Analysis By Market Taxonomy, 2014 to 2021
19.10.3. Market Size (US$ Million) & Volume Units Forecast By Market Taxonomy, 2022 to 2029
19.10.3.1. By Injury
19.10.3.2. By Therapy
19.10.3.3. By Distribution Channel
19.10.4. Market Attractiveness Analysis
19.11. Australia Market Analysis 2014 to 2021 and Forecast 2022 to 2029
19.11.1. Introduction
19.11.2. Historical Market Size (US$ Million) & Volume Units Trend Analysis By Market Taxonomy, 2014 to 2021
19.11.3. Market Size (US$ Million) & Volume Units Forecast By Market Taxonomy, 2022 to 2029
19.11.3.1. By Injury
19.11.3.2. By Therapy
19.11.3.3. By Distribution Channel
19.11.4. Market Attractiveness Analysis
19.12. South Africa Market Analysis 2014 to 2021 and Forecast 2022 to 2029
19.12.1. Introduction
19.12.2. Historical Market Size (US$ Million) & Volume Units Trend Analysis By Market Taxonomy, 2014 to 2021
19.12.3. Market Size (US$ Million) & Volume Units Forecast By Market Taxonomy, 2022 to 2029
19.12.3.1. By Injury
19.12.3.2. By Therapy
19.12.3.3. By Distribution Channel
19.12.4. Market Attractiveness Analysis
19.13. GCC Countries Market Analysis 2014 to 2021 and Forecast 2022 to 2029
19.13.1. Introduction
19.13.2. Historical Market Size (US$ Million) & Volume Units Trend Analysis By Market Taxonomy, 2014 to 2021
19.13.3. Market Size (US$ Million) & Volume Units Forecast By Market Taxonomy, 2022 to 2029
19.13.3.1. By Injury
19.13.3.2. By Therapy
19.13.3.3. By Distribution Channel
19.13.4. Market Attractiveness Analysis
20. Market Structure Analysis21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive
21.3.1. Novartis
21.3.1.1. Overview
21.3.1.2. Product Portfolio
21.3.1.3. Profitability by Market Segments (Product/Channel/Region)
21.3.1.4. Sales Footprint
21.3.1.5. Strategy Overview
21.3.1.5.1. Promotional Strategy
21.3.1.5.2. Product Strategy
21.3.2. Pfizer Inc.
21.3.2.1. Overview
21.3.2.2. Product Portfolio
21.3.2.3. Profitability by Market Segments (Product/Channel/Region)
21.3.2.4. Sales Footprint
21.3.2.5. Strategy Overview
21.3.2.5.1. Promotional Strategy
21.3.2.5.2. Product Strategy
21.3.3. Merck & Co.
21.3.3.1. Overview
21.3.3.2. Product Portfolio
21.3.3.3. Profitability by Market Segments (Product/Channel/Region)
21.3.3.4. Sales Footprint
21.3.3.5. Strategy Overview
21.3.3.5.1. Promotional Strategy
21.3.3.5.2. Product Strategy
21.3.4. Biocon Ltd.
21.3.4.1. Overview
21.3.4.2. Product Portfolio
21.3.4.3. Profitability by Market Segments (Product/Channel/Region)
21.3.4.4. Sales Footprint
21.3.4.5. Strategy Overview
21.3.4.5.1. Promotional Strategy
21.3.4.5.2. Product Strategy
21.3.5. Teva Pharmaceutical Industries Ltd.
21.3.5.1. Overview
21.3.5.2. Product Portfolio
21.3.5.3. Profitability by Market Segments (Product/Channel/Region)
21.3.5.4. Sales Footprint
21.3.5.5. Strategy Overview
21.3.5.5.1. Promotional Strategy
21.3.5.5.2. Product Strategy
21.3.6. Mylan Pharmaceuticals Inc.
21.3.6.1. Overview
21.3.6.2. Product Portfolio
21.3.6.3. Profitability by Market Segments (Product/Channel/Region)
21.3.6.4. Sales Footprint
21.3.6.5. Strategy Overview
21.3.6.5.1. Promotional Strategy
21.3.6.5.2. Product Strategy
21.3.7. NIPRO Medical
21.3.7.1. Overview
21.3.7.2. Product Portfolio
21.3.7.3. Profitability by Market Segments (Product/Channel/Region)
21.3.7.4. Sales Footprint
21.3.7.5. Strategy Overview
21.3.7.5.1. Promotional Strategy
21.3.7.5.2. Product Strategy
21.3.8. Baxter Corporation
21.3.8.1. Overview
21.3.8.2. Product Portfolio
21.3.8.3. Profitability by Market Segments (Product/Channel/Region)
21.3.8.4. Sales Footprint
21.3.8.5. Strategy Overview
21.3.8.5.1. Promotional Strategy
21.3.8.5.2. Product Strategy
21.3.9. Asahi Kasei
21.3.9.1. Overview
21.3.9.2. Product Portfolio
21.3.9.3. Profitability by Market Segments (Product/Channel/Region)
21.3.9.4. Sales Footprint
21.3.9.5. Strategy Overview
21.3.9.5.1. Promotional Strategy
21.3.9.5.2. Product Strategy
21.3.10. NIKKISO
21.3.10.1. Overview
21.3.10.2. Product Portfolio
21.3.10.3. Profitability by Market Segments (Product/Channel/Region)
21.3.10.4. Sales Footprint
21.3.10.5. Strategy Overview
21.3.10.5.1. Promotional Strategy
21.3.10.5.2. Product Strategy
21.3.11. Fresenius Medical Care
21.3.11.1. Overview
21.3.11.2. Product Portfolio
21.3.11.3. Profitability by Market Segments (Product/Channel/Region)
21.3.11.4. Sales Footprint
21.3.11.5. Strategy Overview
21.3.11.5.1. Promotional Strategy
21.3.11.5.2. Product Strategy
22. Assumptions and Acronyms Used23. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 01: Global Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, By Product Type
Table 02: Global Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, By Product Type
Table 03: Global Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, By Distribution Channel
Table 04: Global Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, By Region
Table 05: North America Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, By Country
Table 06: North America Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, By Product Type
Table 07: North America Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, By Injury Type
Table 08: North America Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, ByDistribution Channel
Table 09: Latin America Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, By Country
Table 10: Latin America Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, By Product Type
Table 11: Latin America Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, By Injury Type
Table 12: Latin America Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, ByDistribution Channel
Table 13: Europe Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, By Country
Table 14: Europe Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, By Product Type
Table 15: Europe Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, By Injury Type
Table 16: Europe Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, ByDistribution Channel
Table 17: South Asia Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, By Country
Table 18: South Asia Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, By Product Type
Table 19: South Asia Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, By Injury Type
Table 20: South Asia Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, ByDistribution Channel
Table 21: East Asia Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, By Country
Table 22: East Asia Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, By Product Type
Table 23: East Asia Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, By Injury Type
Table 24: East Asia Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, By Distribution Channel
Table 25: Oceania Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, By Country
Table 26: Oceania Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, By Product Type
Table 27: Oceania Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, By Injury Type
Table 28: Oceania Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, By Distribution Channel
Table 29: MEA Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, By Country
Table 30: MEA Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, By Product Type
Table 31: MEA Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, By Injury Type
Table 32: MEA Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, By Distribution Channel
Table 33: India Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, By Product Type
Table 34: India Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, By Injury Type
Table 35: India Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, By Distribution Channel
Table 36: China Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, By Product Type
Table 37: China Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, By Injury Type
Table 38: China Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, By Distribution Channel
Table 39: Brazil Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, By Product Type
Table 40: Brazil Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, By Injury Type
Table 41: Brazil Market Size (US$ Million) Analysis 2014 to 2021 and Opportunity Assessment 2022 to 2029, By Distribution Channel
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 01: Global Historical Market Size and Y-o-Y, 2014 to 2021
Figure 02: Global Market Size (US$ Million) & Y-o-Y Growth (%), 2022 to 2029
Figure 03: Global Market Absolute $ Opportunity, 2014-2029
Figure 04: Global Market Y-o-Y Growth Projections by Product Type, 2022 to 2029
Figure 05: Global Market Attractiveness Analysis by Product Type, 2022 to 2029
Figure 06: Global Market Attractiveness Analysis, By Product Type
Figure 07: Global Market Analysis by Injury Type - 2022 & 2029
Figure 08: Global Market Y-o-Y Growth Projections by Injury Type, 2022 to 2029
Figure 09: Global Market Attractiveness Analysis, By Injury Type
Figure 10: Global Market Share Analysis (%) By Distribution Channel, 2022 & 2029
Figure 11: Global Market Y-o-Y Growth (%) By Distribution Channel, 2022 to 2029
Figure 12: Global Market Attractiveness Analysis, By Distribution Channel
Figure 13: Global Market Share Analysis (%) By Region, 2022 & 2029
Figure 14: Global Market Y-o-Y Growth (%) By Region, 2022 to 2029
Figure 15: Global Market Attractiveness Analysis, By Region
Figure 16: North America Market Size (US$ Million), 2014 to 2021
Figure 17: North America Market Size (US$) & Y-o-Y Growth (%), 2022 to 2029
Figure 18: North America Market Analysis by Country – 2022 & 2029
Figure 19: North America Market Y-o-Y Growth Projections by Country, 2022 to 2029
Figure 20: North America Market Attractiveness Analysis by Country, 2022 to 2029
Figure 21: North America Market Analysis by Product Type - 2022 & 2029
Figure 22: North America Market Y-o-Y Growth Projections by Product Type, 2022 to 2029
Figure 23: North America Market Attractiveness Analysis by Product Type, 2022 to 2029
Figure 24: North America Market Attractiveness Analysis by Distribution Channel, 2022 to 2029
Figure 25: North America Market Attractiveness Analysis by Injury Type, 2022 to 2029
Figure 26: Latin America Market Size (US$ Million), 2014 to 2021
Figure 27: Latin America Market Size (US$) & Y-o-Y Growth (%), 2022 to 2029
Figure 28: Latin America Market Analysis by Country – 2022 & 2029
Figure 29: Latin America Market Y-o-Y Growth Projections by Country, 2022 to 2029
Figure 30: Latin America Market Attractiveness Analysis by Country, 2022 to 2029
Figure 31: Latin America Market Analysis by Product Type – 2022 & 2029
Figure 32: Latin America Market Y-o-Y Growth Projections by Product Type, 2022 to 2029
Figure 33: Latin America Market Attractiveness Analysis by Product Type, 2022 to 2029
Figure 34: Latin America Market Attractiveness Analysis by Distribution Channel, 2022 to 2029
Figure 35: Latin America Market Attractiveness Analysis by Injury Type, 2022 to 2029
Figure 36: Europe Market Size (US$ Million), 2014 to 2021
Figure 37: Europe Market Size (US$) & Y-o-Y Growth (%), 2022 to 2029
Figure 38: Europe Market Analysis by Country – 2022 & 2029
Figure 39: Europe Market Y-o-Y Growth Projections by Country, 2022 to 2029
Figure 40: Europe Market Attractiveness Analysis by Country, 2022 to 2029
Figure 41: Europe Market Analysis by Product Type – 2022 & 2029
Figure 42: Europe Market Y-o-Y Growth Projections by Product Type, 2022 to 2029
Figure 43: Europe Market Attractiveness Analysis by Product Type, 2022 to 2029
Figure 44: Europe Market Attractiveness Analysis by Distribution Channel, 2022 to 2029
Figure 45: Europe Market Attractiveness Analysis by Injury Type, 2022 to 2029
Figure 46: South Asia Market Size (US$ Million), 2014 to 2021
Figure 47: South Asia Market Size (US$) & Y-o-Y Growth (%), 2022 to 2029
Figure 48: South Asia Market Analysis by Country – 2022 & 2029
Figure 49: South Asia Market Y-o-Y Growth Projections by Country, 2022 to 2029
Figure 50: South Asia Market Attractiveness Analysis by Country, 2022 to 2029
Figure 51: South Asia Market Analysis by Product Type – 2022 & 2029
Figure 52: South Asia Market Y-o-Y Growth Projections by Product Type, 2022 to 2029
Figure 53: South Asia Market Attractiveness Analysis by Product Type, 2022 to 2029
Figure 54: South Asia Market Attractiveness Analysis by Distribution Channel, 2022 to 2029
Figure 55: South Asia Market Attractiveness Analysis by Injury Type, 2022 to 2029
Figure 56: East Asia Market Size (US$ Million), 2014 to 2021
Figure 57: East Asia Market Size (US$) & Y-o-Y Growth (%), 2022 to 2029
Figure 58: East Asia Market Analysis by Country – 2022 & 2029
Figure 59: East Asia Market Y-o-Y Growth Projections by Country, 2022 to 2029
Figure 60: East Asia Market Attractiveness Analysis by Country, 2022 to 2029
Figure 61: East Asia Market Analysis by Product Type – 2022 & 2029
Figure 62: East Asia Market Y-o-Y Growth Projections by Product Type, 2022 to 2029
Figure 63: East Asia Market Attractiveness Analysis by Product Type, 2022 to 2029
Figure 64: East Asia Market Attractiveness Analysis by Distribution Channel, 2022 to 2029
Figure 65: East Asia Market Attractiveness Analysis by Injury Type, 2022 to 2029
Figure 66: Oceania Market Size (US$ Million), 2014 to 2021
Figure 67: Oceania Market Size (US$) & Y-o-Y Growth (%), 2022 to 2029
Figure 68: Oceania Market Analysis by Country – 2022 & 2029
Figure 69: Oceania Market Y-o-Y Growth Projections by Country, 2022 to 2029
Figure 70: Oceania Market Attractiveness Analysis by Country, 2022 to 2029
Figure 71: Oceania Market Analysis by Product Type – 2022 & 2029
Figure 72: Oceania Market Y-o-Y Growth Projections by Product Type, 2022 to 2029
Figure 73: Oceania Market Attractiveness Analysis by Product Type, 2022 to 2029
Figure 74: Oceania Market Attractiveness Analysis by Distribution Channel, 2022 to 2029
Figure 75: Oceania Market Attractiveness Analysis by Injury Type, 2022 to 2029
Figure 76: MEA Market Size (US$ Million), 2014 to 2021
Figure 77: MEA Market Size (US$) & Y-o-Y Growth (%), 2022 to 2029
Figure 78: MEA Market Analysis by Country – 2022 & 2029
Figure 79: MEA Market Y-o-Y Growth Projections by Country, 2022 to 2029
Figure 80: MEA Market Attractiveness Analysis by Country, 2022 to 2029
Figure 82: MEA Market Y-o-Y Growth Projections by Product Type, 2022 to 2029
Figure 83: MEA Market Attractiveness Analysis by Product Type, 2022 to 2029
Figure 84: MEA Market Attractiveness Analysis by Distribution Channel, 2022 to 2029
Figure 85: MEA Market Attractiveness Analysis by Injury Type, 2022 to 2029
Figure 86: Emerging Countries Market Size (US$ Million) Analysis, 2022
Figure 87: Emerging Countries Market Size (US$ Million) 2014 to 2029
Figure 88: India Market Size (US$ Million), 2014 to 2021
Figure 89: India Market Size (US$) & Y-o-Y Growth (%), 2022 to 2029
Figure 90: India a Market Analysis by Product Type - 2022 & 2029
Figure 91: India Market Y-o-Y Growth Projections by Product Type, 2022 to 2029
Figure 92: India Market Attractiveness Analysis by Product Type, 2022 to 2029
Figure 93: India Market Attractiveness Analysis by Distribution Channel, 2022 to 2029
Figure 94: India Market Attractiveness Analysis by Injury Type, 2022 to 2029
Figure 95: China Market Size (US$ Million), 2014 to 2021
Figure 96: China Market Size (US$) & Y-o-Y Growth (%), 2022 to 2029
Figure 97: China Market Analysis by Product Type - 2022 & 2029
Figure 98: China Market Y-o-Y Growth Projections by Product Type, 2022 to 2029
Figure 99: China China Market Attractiveness Analysis by Product Type, 2022 to 2029
Figure 100: China a Market Attractiveness Analysis by Distribution Channel, 2022 to 2029
Figure 101: China Market Attractiveness Analysis by Injury Type, 2022 to 2029
Figure 102: Brazil Market Size (US$ Million), 2014 to 2021
Figure 103: Brazil Market Size (US$) & Y-o-Y Growth (%), 2022 to 2029
Figure 104: Brazil Market Analysis by Product Type - 2022 & 2029
Figure 105: Brazil Market Y-o-Y Growth Projections by Product Type, 2022 to 2029
Figure 106: Brazil Market Attractiveness Analysis by Product Type, 2022 to 2029
Figure 107: Brazil Market Attractiveness Analysis by Distribution Channel, 2022 to 2029
Figure 108: Brazil Market Attractiveness Analysis by Injury Type, 2022 to 2029
Figure 109: MEA Market Analysis by Product Type - 2022 & 2029
